Waizel-Haiat Salomón, Waizel-Bucay José
Instituto Mexicano del Seguro Social, Centro Médico Nacional Siglo XXI, Hospital de Especialidades Dr. Bernardo Sepúlveda Gutiérrez, Departamento de Otorrinolaringología, Ciudad de México, México.
Instituto Politécnico Nacional, Escuela Nacional de Medicina y Homeopatía. Ciudad de México, México.
Rev Med Inst Mex Seguro Soc. 2021 Feb 2;59(1):4-6. doi: 10.24875/RMIMSS.M21000046.
Some reports have been recently published on olfactory loss in people with severe COVID-19. It is suggested to take into consideration the recommendations of the American Academy of Otolaryngology and the British Association of Otorhinolaryngology to include olfactory loss as an early clinical symptom of COVID-19 and consider sudden olfactory loss, as a high index of suspicion of SARS-CoV-2 infection. It can be established that the majority of patients with olfactory loss due to COVID-19, present hyposmia and not anosmia. Patients with olfactory loss, who had SARS-CoV-2 infection, should be classified as loss secondary to viral infection.
最近有一些关于重症新冠肺炎患者嗅觉丧失的报道。建议参考美国耳鼻咽喉头颈外科学会和英国耳鼻咽喉头颈外科学会的建议，将嗅觉丧失列为新冠肺炎的早期临床症状，并将突发性嗅觉丧失视为高度怀疑感染SARS-CoV-2的指标。可以确定的是，大多数新冠肺炎导致嗅觉丧失的患者表现为嗅觉减退而非嗅觉丧失。感染SARS-CoV-2的嗅觉丧失患者应归类为继发于病毒感染的嗅觉丧失。
